News
Why it matters: In addition to ongoing clinical trial progress for BNT327, BioNTech was active on the business development ...
These three dividend payers have an average yield of 4.5%. David Harrell: Hi, I’m David Harrell, editor of the Morningstar ...
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than ...
Resting-state EEG (RS-EEG) has emerged as a non-invasive, low-cost tool for Alzheimer’s disease (AD) diagnosis and ...
Converging evidence supports a key pathogenic role of the glymphatic system in the accumulation of pathological aggregates in ...
StockStory.org on MSN7h
Earnings To Watch: Royalty Pharma (RPRX) Reports Q2 Results Tomorrow
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be announcing earnings results this Wednesday before the bell.
Central Indiana’s radiopharmaceutical industry continues to expand rapidly, earning the state a new title from the U.S.
During a live event, Hans Lee, MD, and participants discussed potential approaches to modifying frontline multiple myeloma ...
Industry experts from Amazon Business, Bristol Myers Squibb, and SMBC Americas discuss AI-driven procurement strategies at BI ...
The media could not be loaded, either because the server or network failed or because the format is not supported.
A recent decision by the U.S. Court of Appeals for the Ninth Circuit hit a trifecta of important legal procedures affecting litigation of Fair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results